eCORE
- Advanced Therapies and Advanced Interventions, Nanomedicine, Transplant & Donation
- Global Health
Team
Group Leader
Israel Molina Romero, María José Buzón Gómez
Principal Investigator (PI)
Meritxell Genescà, Vicenç Falcó, Òscar Len, Joaquín Burgos, Joan Gavaldà, Jordi Navarro, Fernando Salvador, Adrián Sánchez, Núria Serre, Inés Oliveira, Marisa Aznar, Jordi Gómez
Researchers
Dolors Rodríguez, Núria Fernández, Adrià Curran, Isabel Ruiz, Ibai Los Arcos, Pau Bosch, Joan Martínez, Adaia Albasanz, Maider Arando, Diana Pou, Begoña Treviño, Raisa Morales, José Santos, Daniel Pieren, Yasmine Baktash, Carme Ferrer, Montse LLinàs
PhD Students
Paula Suanzes, Juan Espinosa, Ester Márquez, Júlia Sellarés, Arnau Monforte, Jorge García, Vicente Descalzo, Patricia Álvarez, Miguel Villamarin, Blanca Marzo, Anna Falcó, Cristina Kirkegard, Nerea Sánchez, David Perea, Ana Gallego, Cristina Mancebo, Estela Muñoz, Marta Palau
Lab Technicians
Joan Rey, Xavier Gomis
Nursing and Technical Staff
Esperanza Esteban, Marta Sanchiz, Lucía Rodríguez, Paola Vidovic, Bibiana Planas, Elisabet Ferrer, Claudia Broto, Desideria Martínez, Silvina Magnani, Rosa Badía, Nuria Saborit
Publications
Buzon, Maria J; Esperalba, Juliana; Falco, Vicenc; Genesca, Meritxell; Kuguel, Sebastian G; Kuguel, Sebastian G; Mancebo, Cristina; Mancebo, Cristina; Pieren, Daan K J; Rey-Cano, Joan et al
Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by mRNA vaccination compared to infection.
Nat Commun. 2023 Apr 5;14(1):1887
DOI: 10.1038/s41467-023-37559-w
IF: 17.7
Astorga-Gamaza, Antonio; Burgos, Joaquin; Burgos, Joaquin; Buzon, Maria J; Calvet-Mirabent, Marta; Castellvi, Josep; Castellvi, Josep; Curran, Adrian; Curran, Adrian; Falco, Vicenc et al
KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir
Cell Rep Med. 2023 Sep 15:101202
DOI: 10.1016/j.xcrm.2023.101202.
IF: 11.97
Sergio España-Cueto, Inés Oliveira-Souto, Fernando Salvador, Lidia Goterris 5, Begoña Treviño, Adrián Sánchez-Montalvá, Núria Serre-Delcor, Elena Sulleiro, Virginia Rodríguez, Maria Luisa Aznar, Pau Bosch-Nicolau, Juan Espinosa-Pereiro, Diana Pou, Israel Molina
Post-infectious irritable bowel syndrome following a diagnosis of traveller’s diarrhoea: a comprehensive characterization of clinical and laboratory parameters
J Travel Med. 2023 Oct 31;30(6):taad040
DOI: 10.1093/jtm/taad040.
IF: 25.7
Anton, Andres; Bosch-Nicolau, Pau; Burgos, Joaquin; Eremiev, Simeon; Falco, Vicenc; Len, Oscar; Martin-Gomez, Maria Teresa; Rodriguez-Pardo, Dolors; Romero-Herrera, Dani; Sellares-Nadal, Julia et al.
Impact of viral detection in patients with community-acquired pneumonia: An observational cohort study.
Med Clin (Barc). 2023 Aug 17:S0025-7753(23)00468-2
DOI: 10.1016/j.medcli.2023.07.018
IF: 3.9
lbajar-Vinas, Pedro; Choque, Estefa; Dehousse, Aurore; Flores-Chavez, Maria Delmans; Gomez I Prat, Jordi; Gregori, Maria Serrano; Guiu, Isabel Claveria; Molina, Israel; Ouaarab, Hakima; Sulleiro, Elena et al.
Community-based actions in consulates: a new paradigm for opportunities for systematic integration in Chagas disease detection
BMC Infect Dis. 2023 Dec 1;23(1):847.
DOI: 10.1186/s12879-023-08844-2
IF: 3.7
Projects
(LOCAL-NKs) – Estudio de NK residentes de memoria en tejido para el control de infecciones virales
Principal Investigator: María José Buzón Gómez
Agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 363,000 €
Period: 01/09/2022 - 31/08/2025
Plataformas basadas en la immunologia de las mucosas para el desarrollo de vacunas de nueva generación
Principal Investigator: Meritxell Genesca Ferrer
Agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 199,287 €
Period: 01/09/2023 - 31/08/2025
Ferramentas inovadoras para a edUcação e o empoderamento de jovens em políTicas de Saúde SexUal e ReprOdutiva (FUTURO)
Principal Investigator: Maria Luisa Aznar Ruiz de Alegria
Agency: EUROPEAN COMMISSION
Funding: 454,839.16 €
Period: 03/11/2020 - 31/10/2024
The efficacy of Lauric Acid, a dietary fatty acid, at impacting the HIV latent reservoir. The FATHIV clinical study
Principal Investigator: Joaquin Burgos Cibrian
Agency: Instituto de Salud Carlos III
Funding: 135,520 €
Period: 2021 - 30/06/2025
Multicentre Controlled Open Randomized Clinical Trial to assess efficacy and safety of an anti-TB drug combination based on high dose Rifampicin, high dose Moxifloxacin and Linezolid for DS smear positive pulmonary TB during the first 8weeks of treatmen
Principal Investigator: Adrián Sánchez Montalvá
Agency: Instituto de Salud Carlos III
Funding: 187,550 €
Period: 01/01/2021 - 30/06/2025